Published date: 16 February 2021
This notice was replaced on 31 May 2021
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 16 February 2021, last edited 31 May 2021)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Disposable non-chemical medical consumables and haematological consumables - 33141000
Location of contract
BS34 7QH
Value of contract
£100,000
Procurement reference
tender_264706/924571
Published date
16 February 2021
Closing date
23 March 2021
Closing time
2pm
Contract start date
1 June 2021
Contract end date
31 May 2026
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
NHSBT's Clinical Biotechnology Centre has a requirement for specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required
About the buyer
Contact name
Marnie Watkins
Address
500 Northway, North Bristol Park, Filton
Bristol
BS34 7QH
England
Telephone
+441179217241
Website
Share this notice
All content is available under the
